Evidence map›Paper›PMID 29538408›Full record

ArticlePloS one2018

Human embryonic stem cells extracellular vesicles and their effects on immortalized human retinal Müller cells.

Yingqian Peng, Edouard Baulier, Yifeng Ke, Alejandra Young, Novruz B Ahmedli, Steven D Schwartz, Debora B Farber

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Stem cells: past, present, and future.Stem cell research & therapy · 2019
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yingqian PengStein Eye Institute, Department of Ophthalmology, UCLA School of Medicine, Los Angeles, CA, United States of America.
Edouard BaulierStein Eye Institute, Department of Ophthalmology, UCLA School of Medicine, Los Angeles, CA, United States of America.
Yifeng KeStein Eye Institute, Department of Ophthalmology, UCLA School of Medicine, Los Angeles, CA, United States of America.
Alejandra YoungStein Eye Institute, Department of Ophthalmology, UCLA School of Medicine, Los Angeles, CA, United States of America.
Novruz B AhmedliStein Eye Institute, Department of Ophthalmology, UCLA School of Medicine, Los Angeles, CA, United States of America.
Steven D SchwartzStein Eye Institute, Department of Ophthalmology, UCLA School of Medicine, Los Angeles, CA, United States of America.
Debora B FarberStein Eye Institute, Department of Ophthalmology, UCLA School of Medicine, Los Angeles, CA, United States of America.ORCID 0000-0002-3207-697X
Doheny Eye Institute · US

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Vision Research Core at UCLAP30EY000331 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DAVID S WILLIAMS · 1985 to 2026
$16.8M
NCATS NIH HHS UL1 TR000124NEI NIH HHS P30 EY000331NIH HHS UL1TR000124
6 · The paper itself

Abstract

Extracellular vesicles (EVs) released by virtually every cell of all organisms are involved in processes of intercellular communication through the delivery of their functional mRNAs, proteins and bioactive lipids. We previously demonstrated that mouse embryonic stem cell-released EVs (mESEVs) are able to transfer their content to different target retinal cells, inducing morphological and biochemical changes in them. The main objective of this paper is to characterize EVs derived from human embryonic stem cells (hESEVs) and investigate the effects that they have on cultured retinal glial, progenitor Müller cells, which are known to give rise to retinal neurons under specific conditions. This would allow us to establish if hESEVs have a pro-regenerative potential not yet described that could be used in the future for treatment of human retinal degenerative diseases. Initially, we showed that hESEVs are heterogeneous in size, contain mRNAs and proteins involved in the induction and maintenance of stem cell pluripotency and can be internalized by cultured Müller cells. After a single exposure to hESEVs these cells display changes in their gene expression profile, and with multiple exposures they de-differentiate and trans-differentiate into retinal neuronal precursors. hESEVs were then fractionated into microvesicles (MVs) and exosomes (EXOs), which were characterized by size, specific surface proteins and biochemical/molecular components. We demonstrate that despite the similar internalization of non-fractionated hESEVs, MVs and EXOs by Müller progenitor cells, in vitro, only the release of MVs' cargo into the cells' cytoplasm induces specific changes in their levels of pluripotency mRNAs and early retinal proteins. EXOs do not produce any detectable effect. Thus, we conclude that MVs and MVs-containing hESEVs are promising agents that possibly could promote the regeneration of diseased or damaged retinas in vivo through inducing glial Müller cells to become replacement neurons.

Indexed as

Cell-Derived MicroparticlesCells, CulturedEpendymoglial CellsExosomesExtracellular VesiclesHEK293 CellsHuman Embryonic Stem CellsHumansNeurogliaNeuronsPluripotent Stem CellsRegenerationRetinaRNA, MessengerTranscriptomeRNA, Messenger

Identifiers

PMID29538408
PMCPMC5851617
OpenAlexW2794190081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.